25th September 2023
News Targeted Protein Degradation
Sygnature Discovery and UBE Corporation successfully identify potent SHP2 degrader compounds
29th June 2021
Drug Discovery News
Five Arrows invests in Sygnature Discovery
16th June 2021
Drug Discovery News
Sygnature Discovery’s Early CMC Development Expansion: Unveiling New Opportunities
27th April 2021
Drug Discovery News
Sygnature Discovery expands US presence with Bay Area office
25th March 2021
DMPK in vivo pharmacology News
Leading UK Drug Discovery CROs Unite as Sygnature Discovery
18th February 2021
Drug Discovery News
Sygnature Discovery Opens Second Drug Discovery Site at Alderley Park
21st January 2021
Computational Sciences and Informatics Drug Discovery News
Enhancing Molecular Design Services: Sygnature Discovery Adopts OpenEye’s Orion™ Platform
18th January 2021
Bioscience News
Sygnature upgrades western blotting capability with Jess instrument from Protein Simple
11th June 2020
Drug Discovery News
Sygnature assists New York Medical College in the fight against Covid-19
29th May 2020
Bioscience Drug Discovery News
Sygnature Discovery Enhances SPR Capacity with Expansion
28th May 2019
Bioscience News
Sygnature Discovery test-drives SPR-M
6th February 2019
Drug Discovery News
Pathios Therapeutics and Sygnature Discovery sign strategic partnership